Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

News in brief

Dalton’s Boehringer contract renewed

24-Feb-2009

Related topics: Preclinical Research

Canada’s Dalton Pharma Services has had its chemistry services contract with Boehringer Ingelheim renewed.

Under the terms of the deal Dalton will continue to provide support services for development work carried out by the German firm’s local subsidiary.

Dalton president Peter Pekos said: “The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim's deep commitment to research in Canada. We look forward to another successful collaboration with this world class organisation."

Follow us on

Key Industry Events

Partnerships in Clinical Trials

Orlando, FL 32821 / Conference

Read more

Procurecon Pharma 2012

Zurich-Glattpark, 8152 / Conference and exhibition

Read more

Access our events listing